News | October 14, 2011

ASE Study Shows Echocardiography Benefits for Cancer Patients

ASE Study Shows Echocardiography Benefits for Cancer Patients

October 14, 2011 — The American Society of Echocardiography (ASE) is preparing a guideline document on using strain echocardiography to evaluate cancer patients for early signs of cardiac toxicity due to their medical treatments. The group has also funded a research study to enhance identification of patients who are at risk.

The September 2011 death of 51-year-old Kara Kennedy of a heart attack brought the link between cancer treatments and cardiovascular damage into the spotlight for both patients and their physicians. Kennedy, the only daughter of Senator Edward M. Kennedy, was reportedly in remission after having been treated for lung cancer in 2002.

While the direct relationship between her cancer treatment and her death remain unclear, one theory links damage to her heart from her chemo treatments. With this tragedy, physician awareness of the link between specific cancer therapies and heart complications has renewed interest.

In the past, when cancer treatments were not very effective and cancer was usually fatal, little attention was paid to treatment complications. With the advent of more successful cancer therapies that have raised survival rates, concerns about their long-term effects have now become paramount.

“There are 2.2 million survivors of breast cancer in the U.S. alone,” said Juan Carlos Plana, M.D., co-director of cardio-oncology, Cleveland Clinic, “and heart disease, not cancer, is the biggest risk they face.”

When a patient is diagnosed with breast cancer, she (or he) is tested for the HER2 mutation, an aggressive form of cancer that affects 20-25 percent of breast cancer patients; it is typically treated with Doxorubicin, followed by Herceptin.

Unfortunately, as many as one third of patients receiving these two drugs will develop cardiotoxicity, and some will progress to full-blown heart failure. This means they could potentially need mechanical devices or heart transplants in order to survive. 

The advent of strain echocardiography for early identification of cardiac problems is great news for those suffering from many forms of cancer. “The goal is not to stop cancer therapy, but to identify cardiotoxicity early and to protect the heart with medications so heart failure does not become a problem and the cancer treatment can be continued,” Plana explained. “Currently, 17 percent of patients receiving treatment for the most aggressive form of breast cancer have to stop therapy due to heart issues. The sensitivity of strain echo allows early detection so oncologists can treat their patients without fear of the downstream effects of the therapies.”

Plana, who is an ASE fellow and served as medical director of cardiac imaging at Houston’s MD Anderson Cancer Center, now heads a newly-formed cardio-oncology center at the Cleveland Clinic; every patient slated for a cancer therapy with toxicity potential receives an intensive left-ventricular mechanics protocol, which includes both 3-D echocardiography with contrast and strain imaging.

To highlight screening benefits, ASE has collaborated with the European Association of Echocardiography (EAE) and the American Society of Clinical Oncology (ASCO) in a guideline writing group, led by Plana. A previous paper entitled “Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients,” has already outlined exciting progress in this area. ASE expects its new guideline to be available in 2012.

The ASE Education and Research Foundation has also funded a Career Development Award on the use of strain and 3-D echocardiography; the goal is to identify patients at high risk for heart complications even before they start chemotherapy. The lead researcher, ASE member Timothy Tan, MBBS, Ph.D., clinical and research fellow, Massachusetts General Hospital and Harvard Medical School, hopes the research “will increase the understanding of heart failure associated with cancer treatment, potentially helping to decrease its morbidity and mortality.”

For more information: www.asecho.org

Related Content

Youth Football Changes Nerve Fibers in Brain

Statistically significant clusters (red-colored) showing group differences (Control vs. Football) in white matter strain along the primary (F1) and secondary (F2) fibers. While body of corpus callosum (BBC) showed relative shrinkage in Football group, the other clusters showed relative stretching of fibers. PCR: Posterior Corona Radiata, PLIC: Posterior Limb of Internal Capsule, SCR: Superior Corona Radiata, SLF: Superior Longitudinal Fasciculus, SCC: Splenium of Corpus Callosum. Image courtesy of Kim et al.

News | Neuro Imaging | December 07, 2018
Magnetic resonance imaging (MRI) scans show repetitive blows to the head result in brain changes among youth football...
Hitachi Medical Systems Europe Introduces Third-Generation Intelligent Vector Flow Mapping
News | Cardiovascular Ultrasound | December 07, 2018
Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at...
GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform
Technology | Artificial Intelligence | December 05, 2018
GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
Videos | Ultrasound Imaging | November 28, 2018
This is an example of the new Fetal HQ heart and vascular software from GE Healthcare for fetal ultrasound.
Artificial Intelligence May Help Reduce Gadolinium Dose in MRI

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

News | Contrast Media | November 27, 2018
Researchers are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in...
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Clarius Mobile Health Announces Clarius AI Collective Intelligence Ultrasound Platform
News | Ultrasound Imaging | November 21, 2018
Clarius Mobile Health will announce a new collective intelligence ultrasound platform at this year's Radiological...
Civco Medical Solutions Introduces Envision Viral Barrier at RSNA 2018
News | Ultrasound Imaging | November 20, 2018
Civco Medical Solutions will present Envision, the next generation of ultrasound probe covers and scan pads, at the...